| # | Drug | Count |
|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 8 |
| 1 | FUROSEMIDE | 7 |
| 2 | LANSOPRAZOLE | 6 |
| 3 | FINASTERIDE | 5 |
| 4 | FLUOXETINE HYDROCHLORIDE | 5 |
| 5 | GABAPENTIN | 5 |
| 6 | FLUOXETINE | 4 |
| 7 | LAMIVUDINE | 4 |
| 8 | LAMIVUDINE ORAL | 4 |
| 9 | BUROSUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 8 | 0.0063 |
| 1 | BUROSUMAB | 3 | 0.0005 |
| 2 | ACARBOSE | 1 | 0.0003 |
| 3 | ATOVAQUONE | 2 | 0.0002 |
| 4 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| 5 | DASPONE | 2 | 0.0002 |
| 6 | DAPSONE GEL, 5% | 2 | 0.0002 |
| 7 | ASFOTASE ALFA | 2 | 0.0002 |
| 8 | DAPSONE | 2 | 0.0002 |
| 9 | LAMIVUDINE | 4 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 2 | 0.0002 |
| 3 | Antimalarial [EPC] | 2 | 0.0002 |
| 4 | Antiprotozoal [EPC] | 2 | 0.0002 |
| 5 | Sulfone [EPC] | 2 | 0.0002 |
| 6 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0001 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 5 | 0.0000 |
| 8 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 5 | 0.0000 |
| 9 | Antimycobacterial [EPC] | 1 | 0.0000 |